21 year old girl with Asperger’s uses cannabis for symptomatic relief

21 year old girl with Asperger's uses cannabis for symptomatic relief

I’m a 21 year old girl with autism, finding a lot of use in cannabis, when it comes to treating symptoms of Asperger’s Syndrome. It’s lovely how it is capable of driving my mind to food, which is very useful when you want to stay healthy, and it makes me less awkward in social interaction. So I hope you don’t mind me smoking this joint, it will make things easier for the both of us!


About cannabisforautism

An Ashtanga Yoga teacher, dedicated to improving the health and welfare of those involved in mental health issues, substance use or homelessness. I am also striving to put an end to the perception of the substance user as someone who makes incorrect choices. Striving for a world where there are no 'drug abusers' or 'addicts', just substance users with health concerns and sometimes financial and legal confounds. It is possible to use many substances and still remain happier and healthier than your peers. The notion that a substance user must become unhealthier as time goes by is false. I hope you enjoy reading my blog. It's about autism treatments and a few other odds and ends. Thank you and take care, Jules
Image | This entry was posted in Uncategorized and tagged , , , , , . Bookmark the permalink.

One Response to 21 year old girl with Asperger’s uses cannabis for symptomatic relief

  1. fred says:

    US Government Patent on Cannabinoids
    The U.S. Government, as represented by the Department of Health and Human Services (D H H S), filed for a patent on cannabinoids as anti-oxidants and neuroprotectants. U.S. Patent 6630507

    Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuro-protectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease and HIV dementia. Non-psychoactive cannabinoids, such as cannabidiol, are particularly advantageous to use because they avoid toxicity that is encountered with psychoactive cannabinoids at high doses useful in the method of the present invention. A particular disclosed class of cannabinoids useful as neuro-protective antioxidants is formula (I) wherein the R group is independently selected from the group consisting of H, CH.sub.3, and COCH.sub.3. ##STR1##

    Inventor: Hampson; Aidan J. (Irvine, CA), Axelrod; Julius (Rockville, MD), Grimaldi; Maurizio (Bethesda, MD)
    Assignee: The United States of America as represented by the Department of Health and Human Services (Washington, DC)
    Family ID: 26767641
    Appl. No.: 09/674,028
    Filed: February 2, 2001
    PCT Filed: April 21, 1999
    PCT No.: PCT/US99/08769
    PCT Pub. No.: WO99/53917
    PCT Pub. Date: October 28, 1999

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s